ENDRA Life Sciences (NDRA) Tops Q3 EPS by 3c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.40), $0.03 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
• Standard Nuclear (STDN) PT Raised to $20 at UBS